EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intracranial stimulation for pediatric refractory epilepsy: A single institutional experience using evolving therapies

Rohin Singh iD, Megan M J Bauman iD, Karimul Islam, Panagiotis Kerezoudis iD, Sanjeet S Grewal iD, Jonathon J Parker, Jamie J Van Gompel iD, Kai J Miller iD, Brian N Lundstrom iD, Keith Starnes

Epilepsia Open · 2025-06 · 10 (3) · 694-704

DOI: 10.1002/epi4.70006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2025-04. Verfasst von Rohin Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Rochester, Rochester, New York, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Deep Brain Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Neuromodulation for pediatric refractory epilepsy (PRE) is preferred when the seizure onset zone is not amenable to surgical resection, due to multifocal onset or involvement of eloquent cortex. Given its rapidly evolving landscape, we describe our institutional experience with neurostimulation therapies including deep brain stimulation (DBS) of the anterior nucleus (DBS‐ANT), the centromedian nucleus (DBS‐CM), responsive neurostimulation (RNS), and chronic subthreshold stimulation (CSS) to treat PRE.

Methods

A retrospective chart review was conducted to identify pediatric patients (≤18 years of age) who presented to our institution with PRE. Patients were included who had at least 1 year of follow‐up after neurostimulation was started. Patients with ≥50% seizure frequency reduction at last follow‐up compared to baseline were classified as responders.

Results

A total of 35 patients (21 females) were included in the series. Nine patients underwent DBS‐ANT, 9 underwent DBS‐CM (+ ANT in 7 patients), 5 underwent RNS, and 12 underwent CSS. The median age at seizure onset and surgery was 8 and 16 years, respectively. Structural lesions were the most common etiology of epilepsy (54%). Eighteen patients had prior interventions and 13 received invasive EEG. Post‐operative complications following neurostimulation implantation were noted in three patients (9%). However, no permanent deficits were noted. Median follow‐up time was 46 months (range 13–162 months). Twenty‐three patients (59%) were responders (3/9 DBS‐ANT; 7/9 DBS‐CM; 4/5 RNS; 9/12 CSS). Further, median seizure reduction was 25% (DBS‐ANT), 89% (DBS‐CM), 87% (RNS), and 88% (CSS) across the cohort. Six patients (17%) had improved subjective neurocognitive outcomes while the other 29 had stable neurocognitive outcomes. Significance DBS, RNS, and CSS are safe and effective options for PRE. An understanding of treatment approaches can optimize results by tailoring therapy to individual patients. Plain Language Summary This study investigates the use of various neurostimulation therapies for treating pediatric refractory epilepsy (PRE) including deep brain stimulation (DBS), responsive neurostimulation (RNS), and chronic subthreshold stimulation (CSS). Overall, neuromodulation was found to be effective in reducing seizures in most patients, with 59% of patients showing at least a 50% reduction in seizure frequency. Additionally, the treatments were generally safe, with few complications and no instances of permanent deficits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyDeep Brain StimulationHumansChildFemaleMaleAdolescentRetrospective StudiesTreatment OutcomeChild, PreschoolElectroencephalographyFollow-Up Studies

Stichwörter der Autor:innen

epilepsy neurostimulationneuromodulationpediatric DBSpediatric RNSpediatric epilepsypediatric neurostimulation

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Rochester, Rochester, New York, USA.
  • Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida, USA.
  • Department of Neurosurgery, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Rohin Singh, Megan M J Bauman, Panagiotis Kerezoudis, Sanjeet S Grewal, Jamie J Van Gompel, Kai J Miller, Brian N Lundstrom

Zitieren

APA

Singh, R., Bauman, M. M. J., Islam, K., Kerezoudis, P., Grewal, S. S., Parker, J. J., Van Gompel, J. J., Miller, K. J., Lundstrom, B. N., & Starnes, K. (2025). Intracranial stimulation for pediatric refractory epilepsy: A single institutional experience using evolving therapies. Epilepsia Open, 10(3), 694-704. https://doi.org/10.1002/epi4.70006

Vancouver

Singh R, Bauman MMJ, Islam K, Kerezoudis P, Grewal SS, Parker JJ, et al. Intracranial stimulation for pediatric refractory epilepsy: A single institutional experience using evolving therapies. Epilepsia Open. 2025;10(3):694-704. doi:10.1002/epi4.70006

BibTeX
@article{Singh2025,
  author = {Singh, Rohin and Bauman, Megan M J and Islam, Karimul and Kerezoudis, Panagiotis and Grewal, Sanjeet S and Parker, Jonathon J and Van Gompel, Jamie J and Miller, Kai J and Lundstrom, Brian N and Starnes, Keith},
  title = {Intracranial stimulation for pediatric refractory epilepsy: A single institutional experience using evolving therapies},
  journal = {Epilepsia Open},
  year = {2025},
  volume = {10},
  number = {3},
  pages = {694--704},
  doi = {10.1002/epi4.70006}
}
Kostenlos starten →